Glimepiride/ja: Difference between revisions

Glimepiride/ja
Created page with "グリメピリド"
Created page with "<!-- Chemical data --> | IUPAC_name = 3-Ethyl-4-methyl-''N''-[2-(4-<nowiki/>{[(''trans''-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1''H''-pyrrole-1-carboxamide | C = 24 | H = 34 | N = 4 | O = 5 | S = 1 | smiles = O=C3C(/CC)=C(/C)CN3C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2 | StdInChI_Ref = {{stdinchicite|correct|chemspide..."
Tags: Mobile edit Mobile web edit
Line 49: Line 49:
| ChEMBL            = 1481
| ChEMBL            = 1481


<div lang="en" dir="ltr" class="mw-content-ltr">
<!-- Chemical data -->
<!-- Chemical data -->
| IUPAC_name        = 3-Ethyl-4-methyl-''N''-[2-(4-<nowiki/>{[(''trans''-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1''H''-pyrrole-1-carboxamide
| IUPAC_name        = 3-Ethyl-4-methyl-''N''-[2-(4-<nowiki/>{[(''trans''-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1''H''-pyrrole-1-carboxamide
Line 65: Line 64:
}}
}}
<!-- Definition and medical uses -->
<!-- Definition and medical uses -->
'''Glimepiride''' is an [[antidiabetic medication]] within the [[sulfonylurea]] class, primarily prescribed for the management of  [[type 2 diabetes]]. It is regarded as a second-line option compared to [[metformin]], due to metformin's well-established safety and efficacy. Use of glimepiride is recommended in conjunction with [[Lifestyle modification|lifestyle modifications]] such as diet and exercise. It is taken by mouth, reaching a peak effect within three hours and lasting for about a day.
'''グリメピリド'''('''Glimepiride''')は、[[sulfonylurea/ja|スルホニルウレア薬]]クラスの[[antidiabetic medication/ja|抗糖尿病薬]]であり、主に[[type 2 diabetes/ja|2型糖尿病]]の管理に処方される。メトホルミンの安全性と有効性が確立されているため、[[metformin/ja|メトホルミン]]と比較して第二選択薬とみなされている。グリメピリドは、食事療法や運動療法などの[[lifestyle modification/ja|生活習慣の改善]]と併用することが推奨されている。経口で服用し、3時間以内に効果がピークに達し、約1日間持続する。
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<div lang="en" dir="ltr" class="mw-content-ltr">